The effects of safinamide on dysphagia in Parkinson’s disease

The effects of safinamide on dysphagia in Parkinson’s disease
PLoS One. 2023 May 25;18(5):e0286066. doi: 10.1371/journal.pone.0286066. eCollection 2023.ABSTRACTDysphagia is a potentially fatal symptom of Parkinson's disease (PD) and is characterized by frequent silent aspiration, a risk factor for aspiration pneumonia. The transdermal dopamine agonist rotigotine alleviates dysphagia in patients with PD and is more effective than oral levodopa, suggesting the importance of continuous dopaminergic stimulation (CDS) in swallowing. Safinamide ... read more
Source: PubMedPublished on 2023-05-25By Makito Hirano